Axitinib in the successive targeted therapy of patients with metastatic kidney cancer
<p><strong>Background</strong>. There is a global increase in the incidence of renal cell carcinoma (RCC); more than 200 thousand new cases are recorded<br />every year. Despite the high (40–60 %) detection rate for localized RCC, the incidence of locally advanced and metasta...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-11-01
|
| Series: | Onkourologiâ |
| Subjects: | |
| Online Access: | http://oncourology.abvpress.ru/index.php/oncur/article/view/385 |